Erin McCreary, PharmD, BCPS, BCIDP is a Clinical Assistant Professor within the University of Pittsburgh Department of Medicine, Division of Infectious Diseases and the Director of Infectious Diseases Improvement and Clinical Research Innovation for UPMC. She received her PharmD from the Auburn University Harrison School of Pharmacy and completed her PGY1 Pharmacy and PGY2 Infectious Diseases residencies at the University of Wisconsin Health.
Dr. McCreary directs the Office of Quality and Research Innovation, leading multiple clinical trials. She has also led implementation of multiple infectious diseases and antimicrobial stewardship initiatives across a 35-hospital system and published numerous peer-reviewed manuscripts in these areas. During the pandemic, she co-chaired the UPMC COVID-19 Therapeutics Committee and served as a co-investigator for the REMAP-CAP trial, a global, adaptive, clinical trial evaluating multiple therapies for COVID-19. She also designed and implemented the OPTIMISE-C19 trial, the largest comparative effectiveness trial of monoclonal antibody treatment for COVID-19 in the world. She has been integral in design and execution of lottery systems to ethically allocate scarce healthcare resources.
She previously served on the Society of Infectious Diseases Pharmacists Executive Board, ASM Microbe planning committee, and is currently a host of Breakpoints—The SIDP Podcast. She is also a member of the United States Committee on Antimicrobial Susceptibility Testing (USCAST).
Her practice and research interests include infectious diseases and antimicrobial stewardship in immunocompromised hosts, gram-negative resistance, and antimicrobial pharmacokinetic/pharmacodynamic optimization. She is also passionate about professional leadership, mentorship, and preceptorship.
